Sio Capital Management, LLC Portfolio Holdings

Sio Capital Management, LLC

  • $309 Million
  • Q1 2024

Sio Capital Management, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $309 Million distributed in 51 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Laboratory Corp Of America Holdings with a value of $49.4M, Cigna Corp with a value of $27.6M, Globus Medical Inc with a value of $21.1M, Madrigal Pharmaceuticals, Inc. with a value of $13.6M, and Zimmer Biomet Holdings, Inc. with a value of $9.79M.

Examining the 13F form we can see an decrease of $96.2M in the current position value, from $405M to 309M.

Sio Capital Management, LLC is based out at New York, NY

Below you can find more details about Sio Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $309 Million
Healthcare: $309 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$17.5B
$49.4 Million 15.98% of portfolio
225,902
Q1 2024 Added 36.81%
$105B
$27.6 Million 8.95% of portfolio
76,086
Q1 2024 Reduced 34.72%
$5.17B
$21.1 Million 6.83% of portfolio
393,420
Q1 2024 Reduced 26.06%
$4.04B
$13.6 Million 4.41% of portfolio
51,000
Q1 2024 New
$24.2B
$9.79 Million 3.17% of portfolio
74,179
Q1 2024 Added 2.6%
$108B
$9.15 Million 2.96% of portfolio
105,000
Q1 2024 New
$5.42B
$9.01 Million 2.92% of portfolio
479,023
Q1 2024 New
$681M
$8.79 Million 2.85% of portfolio
535,741
Q1 2024 New
$715M
$7.77 Million 2.52% of portfolio
585,418
Q1 2024 Reduced 20.46%
$9.81B
$7.66 Million 2.48% of portfolio
33,878
Q1 2024 Reduced 7.25%
$503M
$6.3 Million 2.04% of portfolio
635,969
Q3 2023 Added 117.02%
$4.15B
$6.28 Million 2.03% of portfolio
203,174
Q1 2024 Added 54.21%
$770M
$6.22 Million 2.01% of portfolio
2,000,000
Q1 2024 New
$1.13B
$6.04 Million 1.96% of portfolio
87,354
Q1 2024 New
$144M
$5.77 Million 1.87% of portfolio
410,267
Q1 2024 New
$799M
$5.26 Million 1.7% of portfolio
421,317
Q1 2024 Reduced 48.01%
$308M
$5 Million 1.62% of portfolio
2,427,184
Q1 2024 New
$69.3M
$4.99 Million 1.61% of portfolio
3,588,427
Q4 2023 Added 38.07%
$485M
$4.86 Million 1.57% of portfolio
273,720
Q1 2024 New
$673M
$4.86 Million 1.57% of portfolio
1,336,231
Q1 2024 New
$2.58B
$4.86 Million 1.57% of portfolio
137,000
Q1 2024 New
$439M
$3.49 Million 1.13% of portfolio
383,026
Q1 2024 Reduced 60.57%
$112M
$3.48 Million 1.13% of portfolio
1,598,590
Q1 2024 New
$258M
$3.09 Million 1.0% of portfolio
177,004
Q1 2024 New
$576M
$3.04 Million 0.99% of portfolio
225,496
Q1 2024 New
$119M
$2.83 Million 0.92% of portfolio
315,000
Q1 2024 New
$17.8M
$2.85 Million 0.92% of portfolio
1,539,352
Q1 2024 Added 123.3%
$234M
$2.31 Million 0.75% of portfolio
468,871
Q1 2024 New
$270M
$2.08 Million 0.67% of portfolio
378,000
Q1 2024 New
$537M
$1.54 Million 0.5% of portfolio
163,363
Q4 2023 New
$140M
$1.52 Million 0.49% of portfolio
320,394
Q4 2023 Reduced 8.46%
$1.76B
$1.45 Million 0.47% of portfolio
33,007
Q4 2023 Reduced 55.4%
$965M
$1.3 Million 0.42% of portfolio
149,400
Q1 2024 New
$243M
$816,000 0.26% of portfolio
121,672
Q4 2023 New
$13.3M
$516,000 0.17% of portfolio
102,049
Q3 2021 Reduced 27.58%
$42.7M
$289,000 0.09% of portfolio
130,000
Q4 2021 New
$0
$29,000 0.01% of portfolio
49,998
Q1 2023 New
Aslan Pharmaceuticals LTD
-
$0 0.0% of portfolio
-
Q1 2023 New
Boundless Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
$0
$0 0.0% of portfolio
12,808
Q1 2023 New
Aprea Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 1.21%
Rocket Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q1 2023 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Gsk PLC
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 53.89%
$0
$0 0.0% of portfolio
536,163
Q1 2024 Reduced 51.52%
Nyxoah Sa
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 74.59%
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 51
  • Current Value $309 Million
  • Prior Value $405 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 21 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email